Allogeneic Transplantation
Tissue Bank Studies
Our Hematology department maintains a robust list of biobank trials for various hematological conditions. These trials enable us to drive innovation, improve diagnostics, and develop more effective treatments, ultimately benefiting our patients and the broader medical community.
COMIRB: 06-0720
University of Colorado Hematology Tissue Bank Protocol
Principal Investigator: Dan Pollyea
Eligibility: Ages ≥ 18; known or suspected to have a hematological malignancy or a non-malignant hematological disorder, or who are at risk of developing a malignancy or a hematological disorder, or are serving as a donor for an allogeneic stem cell transplantation
COMIRB: 17-1038
University of Colorado Lymphoid Malignancies Tissue Bank Protocol
PI: Brad Haverkos
Eligibility: Ages ≥ 18; who are known or suspected to have a lymphoid malignancy or a non-malignant hematological disorder, or who are at risk of developing a malignancy or a hematological disorder
COMIRB: 19-1845
Studying the Tumor Microenvironment of Lymphoma Patients for the Purpose of Improving Future Immunotherapies
PI: Brad Haverkos
Eligibility: Ages ≥ 18; diagnosed lymphoproliferative disorder
Request an Appointment
If you would like to schedule an appointment, please give us a call.
Our intake coordinator will help you navigate the process of becoming a new patient including helping you obtain the necessary referrals, get the necessary medical records transferred, and coordinate care with your existing physicians. We are available to answer your questions about our clinic, your treatment, and participation in ongoing clinical trials.